PHK
OCUL icon

Point72 Hong Kong’s Ocular Therapeutix OCUL Stock Holding History

Point72 Hong Kong’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,162
Closed -$17K – 2268
2022
Q2 		$17K Buy
+4,162
New +$15.7K ﹤0.01% 1593
2021
Q3 		– Sell
-1,326
Closed -$19K – 2314
2021
Q2 		$19K Buy
+1,326
New +$20.2K ﹤0.01% 1653
2020
Q4 		– Sell
-376
Closed -$3K – 1961
2020
Q3 		$3K Sell
376
-522
-58% -$4.33K ﹤0.01% 1101
2020
Q2 		$7K Buy
+898
New +$5.95K ﹤0.01% 1016

Other funds holding OCUL

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Point72 Hong Kong's OCUL Position: Q3 2022 in Review

Point72 Hong Kong sold out of Ocular Therapeutix (OCUL) in Q3 2022, closing a stake of 4,162 shares — an estimated $17K sold.

Point72 Hong Kong first reported a position in OCUL in Q2 2020 and held it in 4 quarters. The position peaked at $19K in Q2 2021. 130 funds tracked by Wall St. Rank hold OCUL as of Q3 2022.

  • Point72 Hong Kong reported no remaining Ocular Therapeutix position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 4,162 Ocular Therapeutix shares in Q3 2022, an estimated $17K.
  • Point72 Hong Kong first reported a position in Ocular Therapeutix in Q2 2020 and held it in 4 quarters.
  • Point72 Hong Kong's Ocular Therapeutix position peaked at $19K in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.